11/18/2026
When oral, sublingual, and IV/SubQ routes are compromised during an acute symptom crisis, how can hospice medical directors equip their field teams with reliable, dignified alternatives?
This Thursday, November 19 at 2:00 PM ET (11:00 AM PT), our partners at the Hospice Medical Director Certification Board® (HMDCB) are hosting a live clinical roundtable: "Re**al Administration in Hospice for Effective Symptom Management."
Join an accomplished panel of hospice and palliative care leaders for a practical clinical discussion on optimizing alternative routes of administration.
➡️ Register here: https://us06web.zoom.us/meeting/register/4j6lzo29SfWIvpmnvUvnrA #/registration
• Catherine S. Spangler RN, BSN, CHS-C — SVP of Clinical Services & Sales, Hospi Corporation (Panelist)
• David Fisher, MD, HMDC — Medical Director & Interim Director of Hospice, Duke HomeCare & Hospice (Panelist)
• Leslie Siegel, Pharm.D., R.Ph., BCPMP — Palliative Care Clinical Pharmacy Specialist, Mayo Clinic (Panelist)
• Bernice Burkarth, MD, FAAHPM, HMDC — Chief Medical Officer, Tufts Medicine Care at Home | President, HMDCB (Moderator)
What the panel will cover:
✔️ Real-world case studies and patient candidacy criteria
✔️ Staff and family acceptance insights
✔️ Actionable clinical guidance to help hospice medical directors standardize care and support field teams
If you’re a hospice physician or medical director, we’d love to have you join us.
Can’t attend live at 2:00 PM ET? Register anyway to receive the recording.
(This webinar is for informational purposes only; CME is not provided for this session.)
--